These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38563879)

  • 41. Choosing a medication brand: Excipients, food intolerance and prescribing in older people.
    Page A; Etherton-Beer C
    Maturitas; 2018 Jan; 107():103-109. PubMed ID: 29169573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinically Significant Food-Drug Interactions.
    Ased S; Wells J; Morrow LE; Malesker MA
    Consult Pharm; 2018 Nov; 33(11):649-657. PubMed ID: 30458907
    [No Abstract]   [Full Text] [Related]  

  • 43. Food allergens submitted to compulsory food labelling in the 50 highest-selling drugs in France.
    Piney D; Commun N; Kanny G
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):309-13. PubMed ID: 17066649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Machine Learning Uncovers Food- and Excipient-Drug Interactions.
    Reker D; Shi Y; Kirtane AR; Hess K; Zhong GJ; Crane E; Lin CH; Langer R; Traverso G
    Cell Rep; 2020 Mar; 30(11):3710-3716.e4. PubMed ID: 32187543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anaphylaxis to intravenous paracetamol containing povidone. A case report and narrative review of excipient allergy related to anaesthesia.
    Preuss JF; Goddard CE; Clarke RC; Platt PR; Sadleir PH
    Anaesth Intensive Care; 2020 Sep; 48(5):404-408. PubMed ID: 33016081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Steroid Allergy: Clinical Features and the Importance of Excipient Testing in a Diagnostic Algorithm.
    Li PH; Wagner A; Thomas I; Watts TJ; Rutkowski R; Rutkowski K
    J Allergy Clin Immunol Pract; 2018; 6(5):1655-1661. PubMed ID: 29408496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered.
    Valeur KS; Holst H; Allegaert K
    Pharmaceut Med; 2018; 32(4):251-258. PubMed ID: 30174435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decision Support for Excipient Risk Assessment in Pharmaceutical Manufacturing.
    Bejarano A; Hewa Nadungodage C; Wang F; Catlin AC; Hoag SW
    AAPS PharmSciTech; 2019 Jun; 20(6):223. PubMed ID: 31214878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.
    Nguyen CT; MacEntee MI; Mintzes B; Perry TL
    Drugs Aging; 2014 Jan; 31(1):55-65. PubMed ID: 24293180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products.
    Boetzel R; Schlingemann J; Hickert S; Korn C; Kocks G; Luck B; Blom G; Harrison M; François M; Allain L; Wu Y; Bousraf Y
    J Pharm Sci; 2023 Jun; 112(6):1615-1624. PubMed ID: 35500671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence.
    García-Arieta A
    Eur J Pharm Sci; 2014 Dec; 65():89-97. PubMed ID: 25236823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined.
    Mill D; Dawson J; Johnson JL
    Ther Adv Drug Saf; 2018 May; 9(5):227-235. PubMed ID: 29796247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. US Generic Antiseizure Medication Supply Chain: Observations from Analysis of US Government Databases.
    Javarayee P; Meylor J; Shahrukh S; Pollock S; Andrade-Machado R; Sah J; Patel H
    Seizure; 2024 Apr; 117():83-89. PubMed ID: 38354597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polyoxylglycerides and glycerides: effects of manufacturing parameters on API stability, excipient functionality and processing.
    Jannin V; Rodier JD; Musakhanian J
    Int J Pharm; 2014 May; 466(1-2):109-21. PubMed ID: 24607211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report.
    Arai Y; Ogawa M; Yamane F; Sumiyoshi N; Arimoto R; Ando Y; Endo D; Nakada T; Sugawara I; Yokoyama H; Shimoyama K; Inomata H; Kawahara Y; Kato M; Arihiro S; Hokari A; Saruta M
    Clin J Gastroenterol; 2020 Dec; 13(6):1200-1204. PubMed ID: 32880812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The activities of drug inactive ingredients on biological targets.
    Pottel J; Armstrong D; Zou L; Fekete A; Huang XP; Torosyan H; Bednarczyk D; Whitebread S; Bhhatarai B; Liang G; Jin H; Ghaemi SN; Slocum S; Lukacs KV; Irwin JJ; Berg EL; Giacomini KM; Roth BL; Shoichet BK; Urban L
    Science; 2020 Jul; 369(6502):403-413. PubMed ID: 32703874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parts per billion of nitrite in microcrystalline cellulose by ion chromatography mass spectrometry with isotope labeled internal standard.
    Zhu K; Kerry M; Serr B; Mintert M
    J Pharm Biomed Anal; 2023 Oct; 235():115648. PubMed ID: 37611458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PharmDE: A new expert system for drug-excipient compatibility evaluation.
    Wang N; Sun H; Dong J; Ouyang D
    Int J Pharm; 2021 Sep; 607():120962. PubMed ID: 34339812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada.
    Noiles K; Vender R
    J Cutan Med Surg; 2010; 14(3):105-14. PubMed ID: 20487670
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.